tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269

Wuxi Biologics (Cayman) (2269) Revenue

Compare
53 Followers

Wuxi Biologics (Cayman) Revenue

Wuxi Biologics (Cayman) had a revenue of 9.95B in the quarter ending Jun 30, 2025, with -1.46%. This bring the company's revenue in the last twelve months to 20.05B, Decreased 7.38%. In the fiscal year ending Dec 31, 2024, Wuxi Biologics (Cayman) had annual revenue of 18.68B with 9.63% growth.
Revenue (ttm)
20.05B
Revenue Growth
16.90%
P/S Ratio
7.33
Revenue/Employee
$1,485,119
Employees
12,575
Market Cap
$136.81B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.68B1.64B+109.63%
Dec 31, 2023
17.03B1.77B+111.56%
Dec 31, 2022
15.27B4.98B+148.38%
Dec 31, 2021
10.29B4.68B+183.35%
Dec 31, 2020
5.61B1.63B+140.88%
Dec 31, 2019
3.98B1.45B+157.18%
Dec 31, 2018
2.53B915.62M+156.56%
Dec 31, 2017
1.62B629.80M+163.68%
Dec 31, 2016
989.03M